HealthEquity Total Assets 2014-2025 | HQY

HealthEquity total assets from 2014 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • HealthEquity total assets for the quarter ending April 30, 2025 were $3.416B, a 5.23% increase year-over-year.
  • HealthEquity total assets for 2025 were $3.449B, a 9% increase from 2024.
  • HealthEquity total assets for 2024 were $3.164B, a 2.42% increase from 2023.
  • HealthEquity total assets for 2023 were $3.089B, a 0.59% decline from 2022.
HealthEquity Annual Total Assets
(Millions of US $)
2025 $3,449
2024 $3,164
2023 $3,089
2022 $3,107
2021 $2,710
2020 $2,565
2019 $510
2018 $369
2017 $279
2016 $220
2015 $159
2014 $55
2013 $46
HealthEquity Quarterly Total Assets
(Millions of US $)
2025-04-30 $3,416
2025-01-31 $3,449
2024-10-31 $3,488
2024-07-31 $3,514
2024-04-30 $3,246
2024-01-31 $3,164
2023-10-31 $3,094
2023-07-31 $3,066
2023-04-30 $3,035
2023-01-31 $3,089
2022-10-31 $3,065
2022-07-31 $3,074
2022-04-30 $3,065
2022-01-31 $3,107
2021-10-31 $3,100
2021-07-31 $3,149
2021-04-30 $3,162
2021-01-31 $2,710
2020-10-31 $2,657
2020-07-31 $2,664
2020-04-30 $2,562
2020-01-31 $2,565
2019-10-31 $2,560
2019-07-31 $1,098
2019-04-30 $597
2019-01-31 $510
2018-10-31 $478
2018-07-31 $455
2018-04-30 $418
2018-01-31 $369
2017-10-31 $356
2017-07-31 $331
2017-04-30 $303
2017-01-31 $279
2016-10-31 $264
2016-07-31 $251
2016-04-30 $232
2016-01-31 $220
2015-10-31 $212
2015-07-31 $203
2015-04-30 $165
2015-01-31 $159
2014-10-31 $153
2014-07-31 $66
2014-04-30 $0
2014-01-31 $0
2013-10-31 $0
2013-07-31 $0
2013-01-31 $46
Sector Industry Market Cap Revenue
Medical Medical Services $8.752B $1.200B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.515B 26.35
CVS Health (CVS) United States $84.516B 10.51
Elevance Health (ELV) United States $84.143B 10.86
Cencora (COR) United States $56.815B 19.77
Natera (NTRA) United States $23.263B 0.00
DiDi Global (DIDIY) China $22.732B 24.15
Labcorp Holdings (LH) United States $21.849B 17.72
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.354B 0.00
CochLear (CHEOY) Australia $12.742B 0.00
Solventum (SOLV) United States $12.673B 13.42
ICON (ICLR) Ireland $11.895B 11.06
Revvity (RVTY) United States $11.192B 19.26
Viatris (VTRS) United States $10.387B 3.57
Avantor (AVTR) United States $9.152B 13.30
Medpace Holdings (MEDP) United States $8.871B 23.56
Sonic Healthcare (SKHHY) Australia $8.201B 0.00
Charles River Laboratories (CRL) United States $7.239B 14.19
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.245B 25.00
BrightSpring Health Services (BTSG) United States $4.003B 36.73
Sotera Health (SHC) United States $3.148B 17.89
Alignment Healthcare (ALHC) United States $2.764B 0.00
Concentras Parent (CON) United States $2.689B 15.54
Surgery Partners (SGRY) United States $2.589B 33.67
Organon (OGN) United States $2.548B 2.71
GeneDx Holdings (WGS) United States $2.274B 87.59
PACS (PACS) United States $1.943B 0.00
Ardent Health (ARDT) United States $1.851B 7.89
Premier (PINC) United States $1.802B 13.68
Progyny (PGNY) United States $1.782B 39.23
GoodRx Holdings (GDRX) United States $1.675B 33.50
Teladoc Health (TDOC) United States $1.384B 0.00
Pediatrix Medical (MD) United States $1.149B 8.74
Establishment Labs Holdings (ESTA) $1.058B 0.00
CareDx (CDNA) United States $1.055B 16.48
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.890B 0.00
AMN Healthcare Services Inc (AMN) United States $0.811B 7.59
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
LifeMD (LFMD) United States $0.650B 0.00
Nutex Health (NUTX) United States $0.649B 9.83
Embecta (EMBC) United States $0.574B 3.87
InnovAge Holding (INNV) United States $0.536B 0.00
Enhabit (EHAB) United States $0.470B 38.67
Auna S.A (AUNA) Luxembourg $0.463B 10.42
Sonida Senior Living (SNDA) United States $0.457B 0.00
SBC Medicals (SBC) United States $0.450B 0.00
Omada Health (OMDA) $0.382B 0.00
Performant Healthcare (PHLT) United States $0.281B 0.00
Beauty Health (SKIN) United States $0.243B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.220B 0.00
Oncology Institute (TOI) United States $0.204B 0.00
DocGo (DCGO) United States $0.172B 28.17
So-Young (SY) China $0.168B 0.00
Pheton Holdings (PTHL) China $0.130B 0.00
OncoCyte (IMDX) United States $0.105B 0.00
KindlyMD (NAKA) United States $0.098B 0.00
Sera Prognostics (SERA) United States $0.070B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.051B 0.00
ModivCare (MODV) United States $0.049B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
Biodesix (BDSX) United States $0.039B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
SeaStar Medical Holding (ICU) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00